Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1215-1216 (22 May), doi:10.1136/bmj.328.7450.1215
May prove to be a panacea
| The first 150 words of the full text of this article appear below. |
For over 80 years exogenous insulin has been given by injection. The injection devices have improveddisposable syringes and pen injection devices are more convenient and less traumatic than the boil to sterilise, use until too blunt devices of yesteryearbut patients and healthcare professionals remain uneasy about the concept of injections. Yet the evidence based drive for increasingly tight glycaemic control means that more patients should be offered more injections. A recent attempt to circumvent the need for injection that may soon hit a clinic near you is the use of the lung as an absorption pathway, with the development of insulins to be taken by inhalation. Two versions, a powder and an aerosol, may be nearing launch.
Insulin can be effective given by inhalation. This was first shown in 1971, although the early work was not pursued, and it was not until 2000 that the modern era of inhaled insulin
Stephanie A Amiel, professor
Department of Medicine, King's College School of Medicine, London SE5 9PJ
K George M M Alberti, professor
Department of Endocrinology and Metabolic Medicine, Imperial College, St Mary's Hospital, London W2 1NY (george.alberti@ncl.ac.uk)
Read all Rapid Responses